Our alliances

Servier is active in partnering with both public and private organizations. We have a range of collaborations and licensing agreements with biotechnology and pharmaceutical companies covering our areas of interest.

 

Recent partnerships

Selection of Servier partnerships worldwide
 
 

Selection of Research and Licensing Collaborations

Biotech Companies Therapeutic area Year
GENEURO (CH)
Neurology (MS) 2014
INTARCIA (USA)
Diabetes 2014
CTI BIOPHARMA (USA)
Oncology 2014
NOVARTIS (CH) Oncology 2014
CELLECTIS (FR) Oncology 2014
XENTION (UK) Cardiology 2013
NERVIANO (IT) Oncology 2013
AMGEN (USA) Cardiology 2013
EOS (IT) / CLOVIS (USA)
Oncology 2012
BIOINVENT (SE) Oncology 2012
MACROGENICS (USA) Oncology 2011/2012
MIRAGEN (USA) Cardiology 2011
GALAPAGOS (NDL) Oncology 2011
INTERCEPT (USA) Metabolic diseases (TGR5 agonists) 2011
BIOREALITES (FR) Oncology (Monoclonal Antibodies) 2011
XOMA (USA) Orphan Diseases/Cardiology/Diabetes 2010
OSTEOLOGIX (USA) Osteoporosis 2010
GALAPAGOS (NDL) Osteoarthritis 2010
KAROS (USA) Osteoporosis 2010
PHARMACYCLICS (USA) Oncology (HDAC inhibitor) 2009
HYBRIGENICS (FR) Oncology 2007/2011
VERNALIS (UK) Drug discovery (cancer) 2007/2011
NORDIC BIOSCIENCE (DK) Osteoporosis/Osteoarthritis 2006/2010
ARMGO (USA) Cardiology 2006
GENFIT (FR) Metabolic Diseases 2004

 

Selection of Strategic Research Alliances

 
Public research organisations Therapeutic area Year
CNRS (FR)
Cardiology 2014
SiGN (Singapour) Oncology 2011/2013
WEIZMANN INSTITUTE (Israel) Oncology 2010
HONG KONG UNIVERSITY (HK)
Osteoporosis 2010
SHANGHAI IMM
Drug discovery & Development 2008/2013
COLUMBIA UNIVERSITY (USA) Cardiology 2006/2008/2012
INSTITUT CURIE (FR) Oncology 2005
INSTITUT PASTEUR (FR) Oncology 2007/2014
HADASSAH (Israel) Diabetes 2009/2014
TECHNION (Israel) Cardiology 2011/2014
INSERM (FR)
Various 2003 onwards
CNRS (FR)
Various 2003 onwards